The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy. (2018)
Attributed to:
MICA: BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2017.08.026
PubMed Identifier: 28987811
Publication URI: http://europepmc.org/abstract/MED/28987811
Type: Journal Article/Review
Volume: 141
Parent Publication: The Journal of allergy and clinical immunology
Issue: 1
ISSN: 0091-6749